Fitbits could predict hospital readmissions after bladder surgery

NCT ID NCT07148765

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether wearable fitness trackers like the Fitbit Sense 2 can help doctors spot early signs of complications in patients recovering from bladder removal surgery. Fifty participants will wear the device and answer daily surveys for up to two weeks before surgery and 30 days after leaving the hospital. If the tracker or survey shows concerning changes, a healthcare provider will contact the patient within 24 hours. The goal is to see if this approach is practical and can identify early warning signs that might prevent hospital readmissions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fitbit Sense 2 wearable device and smartphone survey
What this could lead to: If successful, this could lead to a system where doctors catch post-surgery problems early using wearable data, potentially reducing hospital readmissions.
What could go wrong: This is a small, early feasibility study with only 50 participants, so results may not apply to everyone. The technology might not reliably predict complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms Urinary Bladder, Neurogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER CYSTECTOMY NEUROGENIC BLADDER DISORDER

Contacts and locations

Locations

UPMC

Pittsburgh, Pennsylvania, 15232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.